Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Lipid peroxidation and changes of trace elements in mice treated with paradichlorobenzene.

Authors: Suhua, Wang; Rongzhu, Lu; Changqing, Yin; Guangwei, Xing; Fangan, Han; Junjie, Jing; Wenrong, Xu; Aschner, Michael

Published In Biol Trace Elem Res, (2010 Sep)

Abstract: Paradichlorobenzene (pDCB) has been used as a space deodorant and moth repellant, as well as an intermediate in the chemical industry. Given its broad applications and high volatility, considerable concern exists regarding the adverse health effects of pDCB in the home and the workplace. In this study, changes in lipid peroxidation, antioxidants, and trace element levels in the liver and kidney of pDCB-treated mice were investigated to determine their roles in toxicity. Mice were orally gavaged once daily for seven consecutive days with pDCB (0 (corn oil control), 450, and 900 mg/kg). The level of malondialdehyde (MDA), an end product of lipid peroxidation, markedly increased in the high-dose pDCB group in both the liver and kidney compared with the control group. Changes in hepatic levels of reduced glutathione (GSH) in the pDCB groups were indistinguishable from the control group, while renal levels of reduced GSH in the high-dose pDCB group were significantly lowered in comparison to the control and the low-dose groups. Superoxide dismutase (SOD) activity in the liver of mice treated with pDCB showed a downward trend, whereas there was no consistent trend associated with changes in SOD activity in the kidney. Additionally, renal iron levels in the high-dose pDCB group were significantly decreased compared with the low-dose group and the controls, whereas hepatic iron content in the low-dose pDCB group was significantly lower compared with the controls. Selenium and zinc levels in the kidney were both significantly decreased in the high-dose pDCB group vs. the control and low-dose groups. There were no treatment-induced changes in copper levels in either the kidney or liver. However, a significant increase was found in the liver zinc/copper ratio in the high-dose pDCB group vs. the controls. In addition, blood zinc levels showed a downward trend with increased pDCB dosage. These results suggest that pDCB toxicity is mediated by oxidative damage and tissue-specific alterations in trace element levels both in the liver and the kidney of mice.

PubMed ID: 19888557 Exiting the NIEHS site

MeSH Terms: Animals; Body Weight/drug effects; Carcinogens/administration & dosage; Carcinogens/toxicity; Chlorobenzenes/administration & dosage; Chlorobenzenes/toxicity*; Copper/blood; Copper/metabolism; Female; Glutathione/metabolism; Iron/blood; Iron/metabolism; Kidney/drug effects; Kidney/metabolism; Kidney/pathology; Lipid Peroxidation/drug effects*; Liver/drug effects; Liver/metabolism; Liver/pathology; Male; Malondialdehyde/metabolism; Mice; Organ Size/drug effects; Selenium/blood; Selenium/metabolism; Superoxide Dismutase/metabolism; Trace Elements/metabolism*; Zinc/blood; Zinc/metabolism

Back
to Top